What is LIN's health score?

LINDE PLC (LIN) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LIN's estimated fair value?

Based on our 5-year discounted cash flow model, LINDE PLC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is LIN undervalued or overvalued?

Our model currently rates LIN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

LINDE PLC (LIN)

Materials Overvalued low weak

$522.54

Updated: 2026-07-15

TradeApes Score

Financial Strength

40 Weak

Operating Trend

55 Mixed

Relative Value

15 Stressed

Capital Allocation

35 Weak

Risk Management

70 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Industry Related Stocks

Alcoa Corp (AA) AMERICAN BATTERY TECHNOLOGY Co (ABAT) ASCENT INDUSTRIES CO. (ACNT) American Clean Resources Group, Inc. (ACRG) ADURO CLEAN TECHNOLOGIES INC. (ADUR) ALBEMARLE CORP (ALB)

See all Materials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.